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Abstract
In the last decade, bacterial symbionts have been shown to play an important role in protecting hosts against pathogens.
Wolbachia, a widespread symbiont in arthropods, can protect Drosophila and mosquito species against viral infections. We
have investigated antiviral protection in 19 Wolbachia strains originating from 16 Drosophila species after transfer into the
same genotype of Drosophila simulans. We found that approximately half of the strains protected against two RNA viruses.
Given that 40% of terrestrial arthropod species are estimated to harbour Wolbachia, as many as a fifth of all arthropods
species may benefit from Wolbachia-mediated protection. The level of protection against two distantly related RNA viruses
– DCV and FHV – was strongly genetically correlated, which suggests that there is a single mechanism of protection with
broad specificity. Furthermore, Wolbachia is making flies resistant to viruses, as increases in survival can be largely explained
by reductions in viral titer. Variation in the level of antiviral protection provided by different Wolbachia strains is strongly
genetically correlated to the density of the bacteria strains in host tissues. We found no support for two previously
proposed mechanisms of Wolbachia-mediated protection — activation of the immune system and upregulation of the
methyltransferase Dnmt2. The large variation in Wolbachia’s antiviral properties highlights the need to carefully select
Wolbachia strains introduced into mosquito populations to prevent the transmission of arboviruses.
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Introduction
Heritable symbionts are major players in arthropod evolution
owing to their high incidence and the diversity of effects they have
on their host’s phenotype [1–3]. Primary (obligate) symbionts are
mutualists that play some essential role — typically synthesizing
nutrients missing from the insect’s diet — and they often form
stable associations with their hosts that can last for many millions
of years [4–6]. Secondary (facultative) symbionts have more
diverse effects, which range from parasitism to mutualism [3,7].
The parasites mostly manipulate their host’s reproduction to
enhance their transmission to the next generation, for example by
distorting the sex ratio towards females (the sex that transmits the
bacteria). The mutualists can supply nutrients, or protect against
environmental stresses [8] or natural enemies [9–11]. Further-
more, symbionts can combine several strategies at once, with some
‘Jekyll and Hyde’ strains simultaneously exhibiting mutualistic and
parasitic phenotypes [12].
As secondary symbionts occasionally jump between different
host species [13–16], they can result in rapid evolutionary change
in their hosts. This process may be quite different to selection
acting on the host genome, as when a host acquires a novel
symbiont it can instantly acquire a complex adaptation encoded
by many genes. Striking examples of rapid evolution resulting
from the spread of symbionts include a Rickettsia bacterium
infecting whiteflies which rapidly spread through US populations
by causing sex ratio distortion as well as increased fecundity and
survival [17], and a Spiroplasma bacterium that spread through
populations of Drosophila neotestacea, protecting the hosts against
a parasitic nematode [10].
Wolbachia is a maternally-transmitted alphaproteobacterium
that is estimated to infect around 40% of terrestrial arthropods
[18] and can act as both a parasite and a mutualist. Until recently
it was viewed primarily as a parasite that manipulates host
reproduction, most commonly by inducing cytoplasmic incom-
patibility (CI) [19–23]. CI allows Wolbachia to invade populations
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by causing embryonic mortality when uninfected females mate
with infected males, thus conferring a selective advantage to
infected females [24]. Recently it was discovered that Wolbachia
can also protect Drosophila melanogaster against several RNA
viruses [25,26], and subsequently similar antiviral effects have
been reported in other Drosophila species [27,28], as well as in
mosquitoes [29–32]. In most cases, Wolbachia has been shown to
be associated with a decrease in viral titer [26,27,29]. However,
Wolbachia increased the survival of the flies but had no effect on
viral titer in D. melanogaster infected with Flock House virus
(FHV) [26] as well as in one case in D. simulans infected with
Drosophila C virus (DCV) [27], suggesting that Wolbachia might
also allow its host to tolerate viral infections without affecting the
pathogen load. Wolbachia has also been associated with protection
against filarial nematodes, Plasmodium parasites and pathogenic
bacteria in mosquitoes [29,33–36]. However, it is not known
whether the mechanisms of protection acting against these
parasites are the same that are involved in protection against
viruses.
Antiviral protection by Wolbachia could potentially be used to
control vector-borne diseases such as dengue fever [37,38]. When
artificially introduced into Aedes aegypti, the main vector of
dengue virus, Wolbachia was shown to limit the replication of
dengue virus as well as chikungunya, yellow fever and West Nile
viruses [29,39,40]. Furthermore, when Wolbachia infected mos-
quitoes were released into the wild, the bacterium spread through
the mosquito populations due to the induction of CI [41,42].
In both Drosophila and mosquitoes, different Wolbachia strains
are associated with different levels of antiviral protection
[27,32,39,43,44], even among very closely related strains [45].
The causes of this variation are not entirely clear, as relatively few
Wolbachia strains have been characterized for their level of
protection, not all studies control the host genetic background, and
none have controlled for the confounding effects of the bacterial
phylogeny. Nonetheless, several studies found that the Wolbachia
strains with the highest density within the host provide the
strongest protection against viruses, and tissue tropism may also
play a role [27,30,44–47]. Overall, little is known about how
commonly Wolbachia protects insects against viral infection, how
this trait is distributed across the Wolbachia phylogeny, and
therefore to what extent it has contributed to the evolutionary
success of Wolbachia.
The mechanisms by which Wolbachia protects hosts against
viruses remain to be elucidated. The protection could be caused by
direct interactions between Wolbachia and viruses, competition for
shared resources, or indirectly through the regulation of host gene
expression [26]. In particular, it was speculated that Wolbachia
infection may up-regulate the host immune system. While this was
shown to occur after transinfection of Wolbachia from Drosophila
into Ae. aegypti and Anopheles gambiae [33,48–50], such an effect
was not observed in D. melanogaster naturally infected with
Wolbachia [50–55] or transinfected with a non-native strain [44].
Similarly, the small interfering RNA (siRNA) pathway, which
provides broad-spectrum antiviral defense in insects, is not
required for Wolbachia to confer antiviral protection in flies
[56]. Recent results suggest that, in Ae. aegypti, Wolbachia has an
indirect effect on viral replication through the manipulation of
host microRNAs [57,58]. In this species Wolbachia suppresses the
expression of AaDnmt2, a methyltransferase gene, by up-
regulating the microRNA aae-miR-2940 [57]. Overexpression of
AaDnmt2 decreases Wolbachia density and increases the titer of
Dengue virus, suggesting a causal link between Wolbachia and
viral replication. However, Dnmt2, the homolog of AaDnmt2
found in D. melanogaster, was shown to have an antiviral effect
against Drosophila C virus [59], contradicting the effect observed
in case of dengue infection.
To overcome the lack of experimental tools available for
Wolbachia — the bacterium cannot be cultured outside of insect
cells and cannot be genetically manipulated or cloned — we have
taken a comparative approach, looking for genetic correlations
between levels of antiviral protection and potential causes such as
changes in gene expression. To allow us to do this, we compared
the level of protection of 19 Wolbachia strains from a diverse range
of Drosophila species that we transferred into a common D.
simulans genetic background. We used Drosophila C virus and
Flock House virus, which are both RNA viruses with positive-sense
single-stranded genomes. Drosophila C virus belongs to the family
Dicitroviridae [60] and is naturally found in D. melanogaster and
D. simulans [61–63]. FHV belongs to the family Nodaviridae and
was initially isolated from a beetle [64].
Using this comparative approach, we show that Wolbachia
strains vary considerably in the extent to which they increase the
survival of flies after viral infection. There is little specificity, with
strong genetic correlations between protection against FHV and
DCV, despite these viruses being distantly related. The increases
in survival can largely be explained by Wolbachia reducing viral
titer. The variation in antiviral protection is largely explained by
differences in the density of Wolbachia in host tissues. However,
there is no evidence that either activation of the humoral immune
response or up-regulation of the methyltransferase gene Dnmt2
play any role in antiviral protection.
Results
Diversity of Wolbachia in the genus Drosophila
We assembled a panel of 19 Wolbachia strains that naturally
infect 16 different species of Drosophila (Table 1). We recon-
structed the phylogeny of these strains using sequences from eight
multilocus sequence typing (MLST) genes and a Bayesian method
that accounts for recombination between strains [65]. The
phylogeny reveals that 18 of the strains clustered in what is
commonly regarded as the supergroup A [66], with wMa being
Author Summary
In recent years it has been discovered that many
organisms are infected with bacterial symbionts that
protect them against pathogens. Wolbachia is a bacterial
symbiont that is found in many species of insects, and
several strains are known to protect the insects against
viral infection. We took 19 strains of Wolbachia from
different species of Drosophila fruit flies, transferred them
into Drosophila simulans, and then infected these flies with
two different viruses. We found that about half of the
strains slowed the death of flies after viral infection. Given
that 40% of terrestrial arthropods may be infected with
Wolbachia, this suggests that many species may benefit
from this protection. These increases in survival were
tightly linked to reductions in the levels of the virus in the
insect, suggesting that Wolbachia is reducing the viruses’
ability to replicate. Despite the two viruses we used being
very different, the level of protection that a Wolbachia
strain provided against the two viruses tended to be very
similar, suggesting that a single general mechanism
underlies the antiviral effects. The extent to which a
Wolbachia strain provides protection against viral infection
depends largely on the bacterial density— the more
Wolbachia, the greater the protection.
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the only strain from the supergroup B (Figure 1A). Many of the
strains are very closely related.
To allow us to compare the level of antiviral protection that
the different Wolbachia strains provide to their hosts, we
transferred them into the same inbred D. simulans genetic
background. Eleven of the strains were transferred as part of
this study, and the remaining eight have been reported before
(Table 1).
Wolbachia strains vary in the extent to which they
increase survival after viral infection
Flies from the 19 D. simulans lines carrying the different
Wolbachia strains, together with a Wolbachia-free control, were
stabbed with a needle that had been dipped in DCV, FHV or
Ringer’s solution (2528, 2527 and 2492 flies were stabbed for each
treatment respectively). We then followed their survival for 25 days
(Figure 2A–C). In the mock-infected flies (Ringer), there was
significant heterogeneity among the 20 fly lines (Cox’s mixed-effect
model, x2 = 47, d.f. = 19, P= 0.0004; Figure S1), possibly reflect-
ing either intrinsic effects of Wolbachia on survival or some other
difference between the lines, such as remaining differences in the
host genetic background. The overall survival of the mock-infected
flies was low, likely due to this being a weak inbred stock
(Figure 2C).
There was a substantial variation among Wolbachia strains in
the degree to which they protect their hosts against viral infection
(Figure 2A & B). Twelve of the Wolbachia-infected lines showed
significantly reduced mortality relative to the Wolbachia-free flies
within either the DCV or FHV treatments (Figure 1B & 1C). To
account for the slight variation in the survival of the mock-infected
controls, we tested whether survival of the 20 fly lines was affected
by a statistical interaction between the Wolbachia strain and
infection (whether the flies were infected with a virus or mock-
infected). There was a highly significant interaction for both DCV
and FHV (Cox’s mixed-effect models; DCV: x2 = 127.4, d.f. = 19,
P,10215; FHV: x2 = 107.6, d.f. = 19, P,10214). Using this more
conservative approach of testing for an interaction of Wolbachia
and infection treatment, nine of the 19 Wolbachia strains provided
a significant level of antiviral protection, with six protecting against
both viruses, one protecting against just FHV and two protecting
against just DCV (Table S1). This protective phenotype is
widespread across the Wolbachia phylogeny and is not restricted
to particular clades (Figure 1A–C).
Table 1. Wolbachia strains used in this study.
Wolbachia strain Original Host Species Wolbachia Supergroup Drosophila Lines
wAnaa,c D. ananassaeg A 14024-0371.11m
wAraa,c D. arawakanag A 15182-2260.00m
wBaia,c D. baimaiig A 14028-0481.01m
wBica,c D. bicornutag A 14028-0511.00m
wBora,c D. borealish A PG05.16m
wInna,d D. innubilai A KB183l
wMelCSa,c D. melanogasterj A DrosDel w1118 isom
wMela,e D. melanogastere A KB179l, KB101m
wProa,c D. prosaltansk A WM0019m
wSana,f D. santomeaf A KB161l, STO.9m
wSha,c D. sechelliag A 14021-0248.08m
wMab,f D. simulansf B KB176l, KB153m
wHab,f D. simulansf A KB178l, KB29m
wAub,f D. simulansf A KB177l, KB30m
wStva,c D. sturtevantig A 14043-0871.10m
wTeia,f D. teissierif A KB156l, 0257.0m
wTria,c D. triaurariag A 14028-0651.00m
wTroa,c D. tropicalisg A 14030-0801.0m
wYaka,f D. yakubaf A KB165l, SA3m
uninfectede,f - - KB171l
The Wolbachia strains were traninfected into D. simulans STCP either by
aby microinjection or
bintrogression. The transinfection was done.
cduring this study, or previously by
d[83],
e[82]or
f[23]. The Wolbachia strains were obtained from and/or described by
g[97] (San Diego Drosophila Species Stock Center),
h[98],
i[21],
j[45] and
kWolfgang Miller (unpublished). The fly line names either refer to
lthe transinfected D. simulans stock or
mthe original host.
doi:10.1371/journal.ppat.1004369.t001
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There is a strong genetic correlation in the level of
protection against DCV and FHV
To examine the extent to which the effects of Wolbachia are
specific to different viruses, we estimated the genetic correlation
between protection to DCV and FHV (the proportion of the
genetic variance shared by the two traits). The genetic correlation
between protection to DCV and FHV was high (Model 1:
rg = 0.81, 95% CI: 0.55,0.97; Figure 3A), indicating that most of
the genetic variance in antiviral protection affects both DCV and
FHV. There was no evidence of a genetic correlation between the
survival of virus-infected and mock-infected flies (Model 1, DCV-
Ringer: rg = 0.31, 95% CI =20.37,0.87; Model 1, FHV-Ringer:
rg = 0.61, 95% CI =20.14,0.99).
This genetic correlation between viruses could arise either
because there is a causal relationship between DCV and FHV
protection, or as a consequence of common ancestry (phylogenetic
non-independence). We used a phylogenetic mixed model to
partition the variance in the two traits into a component that can
be explained by correlations across the Wolbachia phylogeny and a
strain specific component that is independent of phylogeny. If
there is a causal link between the traits, then the strength of their
association will be the same for the phylogenetic and strain
components. There was no significant difference in the strength of
the genetic correlation for the phylogenetic and strain-specific
components, consistent with a causal link between the traits. As we
have limited power to separate these effects in a single model, we
also fitted a model with just the phylogenetic effect. This model
again produced a very similar correlation between viruses
(rg = 0.95, 95% CI: 0.84,0.99), and the convergence of parameter
estimates was improved.
Increased survival is genetically correlated to reduced
viral titers
To investigate the effect of Wolbachia on viral titers, flies were
stabbed with DCV or FHV, and relative viral RNA levels
measured at two days post infection (dpi) by reverse transcription-
quantitative PCR (RT-qPCR). For both DCV and FHV, viral
titer was affected by the Wolbachia-infection status of flies
(ANOVA on ln(viral titer); DCV: F19,165 = 23.4, P,10
216;
FHV: F19,166 = 12.1, P,10
216; Figure 4A & 4B). Wolbachia
strains tended to have similar effects on the two viruses, with a
strong positive genetic correlation across the Wolbachia strains
between titers of DCV and FHV (Model 2: rg = 0.75, 95%
CI = 0.48,0.94; Figure 3B).
Wolbachia could increase the survival of Drosophila after
infection either by reducing viral titers (increasing resistance), or
by allowing flies to better cope with infection damage (increasing
tolerance). To test whether Wolbachia provides resistance to
infection, we compared the survival of flies and viral titers across
the 19 Wolbachia strains. Relative to the Wolbachia-free control,
seven of the strains were individually associated with significantly
reduced DCV titers, and five with reduced FHV titers (Figure 4A
& 4B). Interestingly, for the strains wHa in DCV- and wSan in
FHV-infected flies, there was a significant increase in viral RNA
levels (Figure 4A & 4B) and this result was replicable by repeating
the experiment on these lines (J. Martinez, personal observation).
Overall, we found that the titer of both DCV and FHV was
negatively genetically correlated to the survival of DCV and FHV
infected flies respectively (Model 3, DCV: rg =20.77, 95% CI =
20.95,20.49; Model 4, FHV: rg =20.88, 95% CI =21.00,
Figure 1. Phylogeny of Wolbachia strains and respective level of protection and within-host density. (A) The phylogeny is based on the
sequence of the MLST genes 16S rRNA, aspC, atpD, ftsZ, sucB, groEL, coxA and fbpA. Branch labels represent posterior support values. Nodes with less
than 50% support were collapsed. The scale bar indicates time in coalescent units. (B–C) Flies were either infected with (B) DCV or (C) FHV. Survival is
expressed as the negative natural log of the hazard ratio compared to Wolbachia-free flies, as estimated from a Cox’s mixed-effect model. Error bars
are standard errors. Symbols above the bars give the significance relative to the Wolbachia-free controls (*: P,0.05; **: P,0.01; ***: P,0.001). (D)
Wolbachia density is expressed as the ratio of Wolbachia genomic DNA to Drosophila genomic DNA, as estimated by quantitative PCR. Different
letters indicate significant differences based on a Tukey’s honest significance test on ln-transformed data.
doi:10.1371/journal.ppat.1004369.g001
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20.64; Figure 3C & 3D). Therefore, resistance could be the
primary explanation for Wolbachia-induced protection.
To understand how Wolbachia affects the dynamics of
infection, we followed DCV and FHV titers for five days in
Wolbachia-free flies and flies infected with the protective strain
wAu that conferred strong protection against both viruses, the
non-protective strain wSh and wAna, which protected against
DCV but not FHV. In all treatments, including in the presence of
the strongly protective strain wAu, DCV and FHV were able to
replicate within the flies (Figure S2). For example, at 2 dpi, DCV
titres had increased ,18.000-fold in wAu-infected flies compared
to ,290.000-fold in Wolbachia-free flies. At 2 dpi, the timepoint
chosen in the previous experiment, viruses were still in their
growth phase, with a plateau of DCV titres being reached at
around 3 dpi (Figure S2). Resistance conferred by wAu seemed to
occur earlier against FHV (1 dpi at start growth phase) than
against DCV (2 dpi at end growth phase) and viral titers were
reduced from those points on, including at the end of the growth
phase.
Wolbachia density is positively genetically correlated to
antiviral protection
There was significant variation in the relative density of the
different Wolbachia strains (ANOVA on ln(relative density):
F18,150 = 115.6, P,10
216; Figure 1D) in 3–6 day old virus-free
flies (the same age as the flies that were infected to estimate
survival and viral titer). The highest density strain, wMelCS, had
114 fold higher density than the lowest density strain, wBor.
Flies infected with high density Wolbachia strains tended to live
longer after viral infection (Figure 3E & F) and had lower viral
titers. This is reflected in strong genetic correlations between
bacterial density and survival after both DCV and FHV infection
(Model 1; DCV: rg = 0.76, 95% CI: 0.49,0.93; FHV: rg = 0.57,
95% CI: 0.20,0.86). This appears to be a specific effect of
Wolbachia on survival after viral infection as there is no support for
a correlation between Wolbachia density and the survival of the
mock-infected flies in this assay (Model 1; Ringer: rg = 0.18, 95%
CI: 20.41,0.77). Similar to the survival analysis, bacterial density
is negatively genetically correlated with DCV titers (Model 2:
rg =20.53, 95% CI: 20.82,20.13). However, there is no support
for a correlation between FHV titer and Wolbachia density (Model
2: rg =20.29, 95% CI: 20.65,0.18).
To examine whether there is likely to be a causal relationship
between Wolbachia density and survival after viral infection, we
partitioned the variance in these traits into components that are
dependent and independent of the Wolbachia phylogeny. The
regression coefficient of survival against bacterial density was not
significantly different for the phylogenetic and strain components
for the two viruses. We are therefore unable to find evidence to
suggest that this correlation is an artefact of phylogenetic
relatedness, although we would caution that this analysis has very
limited statistical power (non-significant phylogenetic component).
Given this limited power to partition the variance across the two
components, we also fitted a model with phylogenetic component
only, and again the correlations between protection and
Wolbachia density were similar to the model without the
phylogeny (DCV: rg = 0.71, 95% CI: 0.32,0.92; FHV: rg = 0.63,
95% CI: 0.24,0.90).
Antiviral protection is not correlated with immune or
methyltransferase gene expression
We finally investigated if antiviral protection could be explained
by an effect of Wolbachia on host gene expression. We first tested
the hypothesis that Wolbachia prime the immune system of flies,
by measuring the expression of Drosomycin and Diptericin as
reporters of Toll and IMD pathway activation respectively. We did
not detect a significant genetic correlation between expression of
either immune genes and DCV protection (Model 5; Drosomycin:
rg = 0.26, 95% CI: 20.37,0.83; Diptericin: rg =20.05, 95% CI:
20.79,0.66; Figure S3A & S3C) or FHV protection (Model 6;
Drosomycin: rg = 0.25, 95% CI: 20.29,0.72; Diptericin: rg = 0.28,
95% CI: 20.37,0.95; Figure S3B & S3D). Finally, the expression
of a putative candidate for protection, the methyltransferase gene
Dnmt2, was not significantly affected by the Wolbachia-infection
status (ANOVA on ln(expression level); DCV: F16,122 = 1.56, 0.09;
FHV: F16,122 = 0.85, P= 0.63; Figure S3E & S3F) and did not
show any correlation with level of protection in DCV-infected
(Model 5; Dnmt2: rg = 0.12, 95% CI: 20.59,0.90) or FHV-
infected flies (Model 6; Dnmt2: rg =20.35, 95% CI: 20.98,0.49).
Discussion
Protective symbionts can be an important component of an
organism’s defenses against infection, in some cases even being the
Figure 2. Survival of flies carrying different Wolbachia strains or being Wolbachia-free. Flies were either infected with (A) DCV, (B) FHV or
(C) mock-infected with Ringer’s solution.
doi:10.1371/journal.ppat.1004369.g002
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primary mode of defense [67]. Despite their importance being
increasingly recognized, studying these symbionts remains chal-
lenging. Many cannot survive outside of host cells, be genetically
manipulated or cloned. Our approach to circumvent these
problems has been to assemble a large panel of different Wolbachia
strains in a common host genetic background. This allows us to
detect genetic correlations between traits, and infer whether these
traits are causally linked.
Our results suggest that symbionts may play a role in protecting
a substantial proportion of insect species against viral infection.
Wolbachia is probably the most widespread symbiont in arthro-
pods [68] and its wide distribution is partly attributable to its
ability to manipulate host reproduction as well as its tendency to
be horizontally-acquired between different host species over
evolutionary time scales [2]. Recently, it has been shown to
confer protection against natural enemies, in particular against
RNA viruses [25,26,29]. By assessing the level of protection
among several Wolbachia strains, we showed that, far from being
an exception, Wolbachia-mediated protection is a common
phenomenon, which could potentially have contributed to its
evolutionary success.
Among the tested strains, about half were able to confer some
level of protection in D. simulans. Assuming that Wolbachia is
found in 40% of arthropod species [18], our results suggest that
20% of arthropods may benefit from such a protection. This
extrapolation relies on strains retaining their ability to protect their
original host, but the host species could also influence the
expression of the protective phenotype. It was previously shown
Figure 3. Correlation between protection, viral titers and Wolbachia density. Dots indicate mean value of the traits for each Wolbachia
strain. Error bars are standard errors. Solid lines show predicted values from linear regressions for illustrative purposes. rg is the genetic correlation
between traits. (A) Correlation of survival between DCV- and FHV-infected flies (negative natural log of hazard ratios). (B) Correlation between DCV
and FHV titers. (C–D) Correlation between viral titer and survival following (C) DCV infection or (D) FHV infection. Viral titers were estimated as viral
RNA concentrations relative to the Drosophila gene EF1a100E. (E–F) Relationship between Wolbachia density and survival in (E) DCV- and (F) FHV-
infected flies. Wolbachia density was estimated as the ratio between copy numbers ofthe Wolbachia gene atpD and the Drosophila gene Actin 5C.
doi:10.1371/journal.ppat.1004369.g003
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that protective strains native to D. melanogaster also protect
mosquito hosts after artificial transfer. In contrast, the strain wInn,
which did not confer protection in this study, was previously found
to protect against FHV in its original host D. innubila [28]. Host
genotype effects on the Wolbachia density have previously been
found [69,70]. Given the correlation between protection and
density, the expression of protection is likely to be under the
control of both the Wolbachia strain and the host genotype.
Wolbachia has previously been shown to protect insects against
a remarkably taxonomically diverse array of RNA viruses
[25,26,29,31,40]; and this could either reflect a broad-spectrum
antiviral mechanism or Wolbachia may have independently
evolved different ways of targeting different viruses. Previously it
has been observed that strains that protect strongly against one
virus tend to protect against other viruses, suggesting the former
explanation is true [27,44–45]. We found that an estimated 81%
(rg = 0.81) of the genetic variation among strains in DCV and
FHV protection is common to the two viruses. Furthermore, this
pattern appears to be independent of the bacterial phylogeny,
indicating that the same genes underlie the level of protection to
the two viruses tested. This supports the hypothesis that Wolbachia
has a single broad-spectrum mechanism of antiviral protection.
The increased survival of Wolbachia-infected flies after viral
infection could result from the symbiont increasing either
resistance or tolerance to infection [71,72]. Resistance occurs
where increases in survival are caused by reductions in viral titers,
while tolerance describes the situation where hosts are better able
to survive a given viral load [71]. Both of these effects have been
ascribed to the antiviral properties of Wolbachia in the past
[26,27,29,31,40,44,45]. Our analysis allows us to test the effect of
resistance by estimating the proportion of the variation in survival
that can be explained by differences in viral titer. The genetic
correlation between titer and survival was very high for both
viruses, so in this instance it seems likely that the between-strain
variation in survival is mainly due to resistance to virus infection.
Our data cannot exclude a role for tolerance, as Wolbachia may be
altering the amount of harm that a given viral titre causes.
However, were this to be the case, then it is likely to be a common
underlying link, such as both traits relying on Wolbachia density or
the same mechanism.
In some studies it was shown that Wolbachia infection can lead
to higher viral titers or virus-induced mortality [73,74]. Interest-
ingly, in our experiment two Wolbachia strains were associated
with an increase in viral titer, although not with increased
mortality. This is a tantalizing result, which would suggest care
should be taken when introducing Wolbachia into disease vector
populations. However, we would caution that this result needs to
be investigated in more detail – we measured many traits across
many strains, so rare outliers could be an artefact of confounding
factors like remaining differences in the genetic background of the
strains.
The density of Wolbachia plays a key role in determining the
level of antiviral protection it provides to its host. This has been
previously demonstrated experimentally by manipulating Wolba-
chia density using antibiotics, and by comparisons of high and low
density strains [27,44,45,46]. Our results strengthen this conclu-
sion, as we show that the relationship of density and survival is
strong and highly significant across a large panel of strains.
Furthermore, this association does not appear to be a consequence
of phylogenetic relatedness, suggesting that higher Wolbachia
density is causing higher levels of resistance to viruses.
Do any factors other than Wolbachia density cause between-
strain variation in the level of resistance to viruses? Our analysis
provides only weak support for other factors being important, as
while the genetic correlation (the proportion of genetic variance
shared) between Wolbachia density and survival ranges from 0.57–
0.76, the upper confidence intervals for all estimates are greater
than 0.86. Therefore, while our data suggests other factors are
important, the evidence is not strong. Any of these Wolbachia
strains may have the intrinsic ability to provide resistance to
Figure 4. Effect of Wolbachia strains on viral titers. (A–B) Relative viral titer in (A) DCV- and (B) FHV-infected flies. Relative titers are normalised
by the mean titer of Wolbachia-free controls (uninfected). Error bars are standard errors. Symbols above the bars give the significance relative to the
Wolbachia-free controls based on a Dunnett’s test (*: P,0.05; **: P,0.01; ***: P,0.001).
doi:10.1371/journal.ppat.1004369.g004
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viruses – they simply need to be present at a sufficiently high
density. If true, it is tempting to speculate what this might imply
about the underlying mechanism of resistance. It seems more
compatible with a mechanism whereby the presence of Wolbachia
per se makes cells or the host less hospitable to viruses, such as
through competition for resources [75] or remodeling of the
cellular environment. In contrast, if Wolbachia was expressing
specific antiviral factors, then these might be easily gained or lost
through evolution, breaking the genetic correlation of resistance
and Wolbachia density. It is likely that various mechanisms can
lead to variation in bacterial density and thus affect within-host
density. For example, it was found recently that a ,21 kb region
encoding eight genes is amplified three to seven times in different
wMelPop isolates relative to wMelCS [45,76], and is associated
with much higher density and stronger protection against viruses
[45]. However, copy number variation of this region does not
explain differences in density or protection between wMelCS and
wMel-like strains [45]. It is therefore tempting to speculate that
genomic differences between Wolbachia strains that confer
differential protection to viruses will only reveal different ways of
varying the bacterial density rather than the actual antiviral
mechanisms.
One way of rendering the host less hospitable for viruses is
through the regulation of host genes. It was argued in the past
that Wolbachia infection may lead to the activation of immune
pathways that in turn could limit the multiplication of other
parasites. Previous studies in mosquitoes showed that even if
Wolbachia can prime the host immune system and increase
antiviral resistance, such an effect is absent in D. melanogaster
[44,50,51,55], and flies deficient in both the Toll and IMD
pathways still display Wolbachia-mediated resistance [54]. In
agreement with previous studies, our results support the
conclusion that Toll and IMD pathways are not required for
antiviral protection since both Drosomycin and Diptericin
expression level (reporters of Toll and IMD pathways respective-
ly) were uncorrelated to the survival of virus-infected flies.
However, other immune pathways and restriction factors could
still be involved.
In the mosquito Ae. aegypti, the methyltransferase AaDnmt2,
whose homolog in Drosophila methylates transfer RNAs and other
nucleic acids, has been proposed as a potential candidate to
explain the antiviral effect of Wolbachia [57]. Wolbachia was
shown to decrease the expression of AaDnmt2 through the
induction of the expression of aae-miR-2940 microRNA. Con-
versely, the overexpression of AaDnmt2 led to a decrease in
Wolbachia density and an increase in the titer of dengue virus.
However, it was recently shown that the Drosophila homolog
Dnmt2 has an antiviral effect against DCV and Nora virus, the
opposite to the pattern seen in mosquito cells infected with dengue
virus [59]. We found that Wolbachia has no consistent effect on
Dnmt2 expression in D. simulans, and variation in Dnmt2
expression does not explain any of the variation in survival after
infection. This suggests changes to Dnmt2 expression are not a
general explanation of the antiviral effects of Wolbachia. It is
possible that a different mechanism of resistance applies to
mosquitoes and dengue virus. However, we would argue that the
critical experiment to reach this conclusion would be to show that
the antiviral effects of Wolbachia on dengue virus require
AaDnmt2 or aae-miR-2940, and this experiment has yet to be
performed.
Together with previous studies, our results show that antiviral
protection is very common among Wolbachia strains. As such, it
has to be taken into account if we are to draw a complete picture
of Wolbachia ecology and evolution. For example, protection may
favor the rapid sweeps of Wolbachia observed in natural
populations [77,78] and explain why strains such as wMel and
wAu, that induce weak or no CI, can be maintained in natural
populations [79,80]. Owing to the high incidence of Wolbachia
and the broad spectrum of viruses affected by the protection, it is
likely that Wolbachia-mediated protection has substantially con-
tributed to the evolution of arthropods. By protecting against
infection, symbiont-based immunity may in turn influence the
evolution of the host immune system. Although the mechanisms
remain to be elucidated, protection is tightly linked to the bacterial
density. Therefore, variation in the selective pressure exerted by
viruses could partly explain why Wolbachia strains vary so much in
density, and why some are found in somatic tissues whereas other
are restricted to the germ cells [81]. From an applied perspective,
our study extends the panel of Wolbachia strains that could be
introduced into mosquito populations to limit the spread of
arboviruses. However, for successful introduction, the choice of a
strain should not only be based on the level of protection but also
consider costs on host fitness and strength of CI that will affect the
invasive potential of Wolbachia.
Materials and Methods
Wolbachia strains, Drosophila lines and fly rearing
The origin of the 19 Wolbachia strains used in this study and
their original host line are listed in Error! Reference source not
found.. To control for host genetic effects, all Wolbachia strains
were transferred into the D. simulans STCP genetic back-
ground. This line was previously obtained through six
generations of brother-sister crossing [23,82,83]. Eight of the
strains were transferred into the STCP background in previous
studies (Table 1; [23,82,83]). Of these, the three strains
naturally-infecting D. simulans were generated by six gener-
ations of backcrossing Wolbachia-infected females to STCP
males, and the remaining five were transferred by microinjec-
tion (Table 1). We microinjected eleven more strains into the
STCP line (Table 1). Microinjections were performed as
previously described using a microcapillary needle to transfer
cytoplasm of infected embryos into uninfected STCP
embryos [82]. All microinjected lines were maintained in the
lab for at least 10 generations before the beginning of the
experiments.
Two generations before the beginning of the experiments,
the Wolbachia infection status of the STCP lines was checked
by PCR using the diagnostic primers wsp81F and wsp691R
[84], and the PCR products were sequenced. For strains
microinjected in this study, vertical transmission was also
assessed with PCR by testing 48 offspring per strain originating
from Wolbachia-infected mothers (data not shown). Three fly
stocks, transinfected with the strains wBai, wBic and wBor,
showed imperfect vertical transmission (54%, 91% and 62%
respectively). For those three strains, the presence of Wolbachia
was checked by PCR one generation before each experiment
and only offspring from infected mothers were used in the
experiments. Additionally, in qPCR assays (see below), flies of
those three strains that were used in the experiments were first
isolated individually, their Wolbachia infection status was
confirmed and only Wolbachia-infected individuals were kept
and pooled in groups of 4–6 flies.
For all the experiments, flies were maintained on a cornmeal
diet (agar: 1%, dextrose: 8.75%, maize: 8.75%, yeast: 2%, nipagin:
3%) at a constant temperature of 25uC with a 12-hour light/dark
cycle at 70% relative humidity.
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Inference of the Wolbachia phylogeny
The phylogeny of the 19 Wolbachia strains was inferred from
the partial sequences of the eight genes 16S rRNA, aspC, atpD,
ftsZ, sucB, groEL, coxA and fbpA previously used in Multilocus
Sequence Typing studies [66,85]. The gene sequences were
either obtained from GenBank, or were sequenced using the
protocol described in Paraskevopoulos et al. (2006). Accession
numbers and the origins of the sequences are described in Table
S2. Each gene was individually aligned using Mauve v2.3.1 [86]
and the phylogeny was inferred using ClonalFrame v1.2 to take
into account recombination between strains [65]. To check for
convergence, 9 independent runs were done with 100,000
MCMC iterations after 100,000 burn-in iterations with param-
eter recording every 100 iterations. For the first 8 runs, a
uniformly chosen coalescent tree was used as the initial tree, and
for the 9th run, a UPGMA tree was used. The UPGMA starting
tree was compared to the eight other trees and showed a good
convergence with seven of them based on the tree comparison
tool implemented in ClonalFrame v1.2 [65]. Parameter
estimates for the UPGMA starting tree also showed a good
convergence based on the Gelman and Rubin test [87] in
ClonalFrame v1.2. A consensus tree with branch support values
was built from the posterior sample of the UPGMA starting tree
at 50% majority-rule in MEGA 5.2 [88] and visualized in R
using the ape package [89]. The consensus tree was visually
compared with a tree inferred from the concatenated sequence
of the eight genes using PhyML v3.1 with 500 bootstrap
replicates [90] to assess the effect of recombination on the
phylogenetic signal. All clades inferred from ClonalFrame were
retrieved in the maximum likelihood tree. Therefore, the
ClonalFrame tree with the UPGMA starting tree was used in
further analyses.
Viral isolates
Viruses were produced and titrated as in [26], with minor
changes. DCV was produced and titrated in Schneider’s Line 2
cells (SL-2), while FHV was titrated in Schneider Drosophila line 2
cells (DL2). For each infection assay, one viral aliquot was
defrosted on the day of infection and diluted in Ringer’s solution
[91] to reach a viral concentration of 56108 TCID50/mL for
DCV and 3.386108 TCID50/mL for FHV.
Survival assay
For each fly line, 3–6 day-old female flies were collected. After
being anaesthetized with CO2, flies were either infected with
DCV, FHV, or mock-infected with Ringer’s solution [91]. The
inoculum was administered by stabbing flies into the left pleural
suture on the thorax with a 0.15 mm diameter anodized steel
needle (Austerlitz Insect Pins) bent,0.25 mm from the end (,half
of the dorsal width of the thorax), dipped into viral or Ringer’s
solution as in [92]. Twenty stabbed flies were placed in a vial of fly
cornmeal medium and dead flies were recorded every day for 25
days after infection. Flies were transferred into fresh vials of food
every 3 days.
The survival assay was replicated on six consecutive days. On
each day two vials of flies from each Wolbachia strain were
assigned to two of the three treatments. The same was done for the
Wolbachia-free flies, except that the number of replicates was
doubled to increase statistical power. The stabbing order of the fly
lines as well as the sequence of treatments were randomized each
day. Mortality that occurred on the day following infection was
attributed to stabbing injuries and was discarded from the
analyses.
Quantitative PCR
The Wolbachia density, DCV and FHV titers as well as the
expression of the three host genes Drosomycin, Diptericin and
Dnmt2 were measured by qPCR on a BioRad iQ5 thermocycler
using primers, probes and cycle conditions listed in Table S3.
Wolbachia density was measured on pools of 10 virus-free 3–6 day-
old female flies (n = 10 pools) from which DNA was extracted
using the Gentra Puregene kit (Qiagen). For viral titers and host
gene expression, 3–6 day-old flies were first infected with DCV or
FHV, as described above, and, 2 days after infection, 10 flies were
pooled (n = 10 pools per virus), homogenized in TRIzol Reagent
(Ambion) and frozen at 280uC. Total RNA was extracted using
the Direct-zol-96 RNA kit (Zymo Research) by following the
manufacturer’s instructions, including a 15 min DNase I digestion
step.
For host gene expression, total RNA was reverse-transcribed
using the GoScript Reverse Transcription System (Promega) with
random primers. Host gene expression and the Wolbachia density
were measured relative to the endogenous control gene actin 5C
(Table S3) using the SensiFAST SYBR & Fluorescein kit (Bioline).
The copy-number of viral genomic RNA was measured relative
to the control gene EF1a100E (Table S3) in a one-step RT-qPCR
reaction using the QuantiTect Virus kit (Qiagen). For each virus,
both viral and fly cDNAs were amplified in a duplex reaction using
virus and fly primers in association with dual-labeled (hydrolysis)
fluorescent probes (Sigma) (Table S3). For each sample, two RT-
qPCR reactions were carried out and the mean of these two
technical replicates was used as the relative viral titer in the
statistical analysis.
The efficiency of the PCR amplication was checked using a
dilution series for each set of primers. The relative Wolbachia
density and viral titers were calculated as follows: 2DCt, where Ct is
the cycle threshold and DCt~Ctfly gene{Ctwolbachia=virus.
Because qPCR efficiencies tended to be different between the
control gene actin 5C and both the immune and the methyltrans-
ferase genes, we use the Pfaffl method to take into account those
differences [93]. As dilution series analysis shows the qPCR
efficiency for actin 5C to be 100%, the relative efficiency E for the
gene of interest can be estimated from the experimental data as
E~2
1
linear regression slopeð Þ. Following [93], Ct values for the gene of
interest were corrected for differences in qPCR efficiency as
Ct
gene
~{log2 E
{Ctgene
 
. Levels of gene expression were then
estimated as follow: 2DCt, where DCt~Ctactin5C{Ct

gene. We also
normalized the results across 96 well plates (sets of samples were
kept in plates for both RNA extraction and qPCR). Thus,
expression level for a given sample j was normalized by the mean,dexpi, and standard deviation ﬃﬃﬃﬃﬃﬃbsi2p of the corresponding plate i for
each gene of interest as follow:
expij{
dexpiﬃﬃﬃﬃﬃﬃbsi2p . The strains wBai, wBic
and wBor were not included in the analysis of host gene
expression.
Time-course analysis of viral infection
In addition to the single timepoint analysis of viral titers,
variation of titers was measured in another infection experiment
for Wolbachia-free flies and for the Wolbachia strains wAu, wSh
and wAna over a 5 day period. Flies were infected with DCV or
FHV and maintained in the same conditions as for the other
infection experiments. Live flies were frozen everyday from the
day of infection until 5 dpi. For each day and each strain, the
RNA was extracted from two pools of ten flies and viral titers
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measured as explained above except that the RT-qPCR was run
on a StepOnePlus thermocycler (Applied Biosystems).
Statistical analysis
Survival data were analyzed with a Cox’s proportional hazards
mixed-effect model using the coxme package in R [89]. The Cox’s
model estimates hazard ratios, which is the probability of a
Wolbachia-infected fly dying at a given time-point divided by the
probability of a Wolbachia-free fly dying. The infection treatment
(DCV, FHV or mock-infected), the Wolbachia infection status (the
19 strains and no Wolbachia) were treated as fixed effects, and the
replicate vial as a random effect. The overall significance of
multilevel factors or their interactions was tested using likelihood
ratio tests to compare models with or without these terms. Flies
that were alive at the end of the experiment were treated as
censored data. Variation in Wolbachia density and viral titers was
analysed using linear models on ln-transformed data to reach the
assumptions of normality and homoscedasticity. Differences in
viral titer with the Wolbachia-free control were assessed using
Dunnett’s tests in order to correct for multiple comparisons.
Genetic correlations between traits were estimated by fitting a
series of multi-response mixed models using a Bayesian approach
in the R package MCMCglmm [94] as follows:
ytwi~btzus:twzetwi
where ytwi is the response of the i
th biological replicate for
Wolbachia strain w, for which we have measured trait t. bt is the
intercept term for trait t with a level for each trait, and it can be
interpreted as the mean trait value across the Wolbachia strains.
The Wolbachia strain random effect, us:tw, is the deviation from
the expected value for trait t in strain w. Random effects were
assumed to be from multivariate normal distributions with zero
mean vectors (illustrated for a model with three traits):
us:t1
us:t2
us:t3
2
64
3
75*N
0
0
0
2
64
3
75,
s2s:t1 ss:t1,t2 ss:t1,t3
ss:t1,t2 s
2
s:t2
ss:t2,t3
ss:t1,t3 ss:t2,t3 s
2
s:t3
2
664
3
775
0
BB@
1
CCA~N(0,Vs)
where s2s:t1 is the genetic variance for trait t1, and ss:t1,t2 is the
genetic covariance between trait t1 and t2. etwi is a residual
capturing the between-vial variation for each trait (within-strain
effects, environmental effects and experimental error). Residuals
were assumed to be normally distributed and a separate variance
was estimated for each trait with the following variance-covariance
structure (illustrated for a model with three traits):
et1
et2
et3
2
64
3
75*N
0
0
0
2
64
3
75,
s2t1 0 0
0 s2t2 0
0 0 s2t3
2
664
3
775
0
BB@
1
CCA~N 0,Ve6Ið Þ
where I is an identity matrix indicating that strain effects within
traits are independent of each other since traits were measured on
different biological replicates.
The traits included in these models included the survival of
DCV-, FHV- or mock-infected flies (estimated as a negative ln
hazard ratio for each vial of flies), the Wolbachia density, viral titer
and gene expression (all estimated as ln 2DCt). We fitted six
different models with different trait combinations. Model 1
included four traits: survival after DCV-, FHV- and mock-
infection, and Wolbachia density. Model 2 included three traits:
DCV titer, FHV titer and Wolbachia density. Models 3 and 4
included two traits for each virus respectively: survival after viral
infection and viral titer. Models 5 and 6 included four traits for
each virus respectively: survival as well as Drosomycin, Diptericin
and Dnmt2 expression levels after viral infection.
Genetic correlations between two traits can arise either because
the traits are causally related or because of phylogenetic non-
independence. To explore these explanations we also fitted a
phylogenetic mixed model, which included an additional random
effect, up:tw, which is the deviation from the expected value for
trait t in strain w due to the phylogeny, i.e. the component of the
between-strain variation that is explained by the phylogeny
[95,96]:
ytwi~btzup:twzus:twzetwi
In this model the strain random effect us:tw is the variation that is
not accounted for by the phylogeny under a Brownian model of
evolution [95]. The intercept bt can be interpreted as the trait
value in the Wolbachia strain at the root of the phylogeny. For the
phylogenetic effect, up:tw, the following variance-covariance
structure was assumed (illustrated for a model with three traits):
up:t1
up:t2
up:t3
2
664
3
775*N
0
0
0
2
664
3
775,
s2p:t1A sp:t1,t2A sp:t1,t3A
sp:t1,t2A s
2
p:t2
A sp:t2,t3A
sp:t1,t3A sp:t2,t3A s
2
p:t3
A
2
6664
3
7775
0
BBB@
1
CCCA
~N 0,Vp6A
 
where A is a matrix with elements ajk standing for the proportion
of time that strain j and k have had shared ancestry since the root
of the phylogeny. s2p:t1 is the variance of the phylogenetic effect
for trait t1, and sp:t1,t2 is the covariance of phylogenetic effects
between trait t1 and t2. Under a Brownian model of evolution, the
phylogenetic covariance between two Wolbachia strains is
inversely proportional to the time since they diverged from their
common ancestor. The phylogenetic effects themselves were
poorly estimated and are therefore not reported. We also fitted
these phylogenetic models without the strain effect as this
improved model convergence and statistical power to test for
genetic correlations.
Independent normal priors with zero mean and large variance
(1010) were used for the fixed effects and are virtually non-
informative in this context. We used several prior probability
distributions for the Vp and Vs covariance matrices to ensure our
results were robust to the prior selected. Results presented were
obtained using parameter expanded priors, but we also fitted
models with inverse-Wishart and flat priors that gave equivalent
results. We also repeated the analyses after removing outliers so
that the distribution of the residuals was normal. In all cases our
conclusions were unaffected by these changes. Finally, models
were run after removing strains wBai, wBic and wBor, since those
strains showed unstable Wolbachia infection status. Estimates of
genetic correlations as well as their statistical significance were very
similar to models that include these 3 strains, and are therefore not
reported. The models were run for 13,000,000 iterations with a
burn-in of 3,000,000. We checked for convergence by visually
examining the trace of the posterior sample and ensuring the
autocorrelation between successive samples in the MCMC chain
was ,0.1. Credible intervals (CI) were estimated from the
posterior distribution of parameter estimates as the 95% highest
posterior density intervals.
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Supporting Information
Figure S1 Estimated effect of Wolbachia on survival in
mock-infected flies (Ringer’s solution). Survival is ex-
pressed as the negative natural log of the hazard ratio compared to
Wolbachia-free flies, as estimated from a Cox’s mixed-effect
model. Error bars are standard errors. Symbols above the bars
give the significance relative to the Wolbachia-free controls
(*: P,0.05; **: P,0.01; ***: P,0.001).
(TIF)
Figure S2 Time-course of viral titers. (A) DCV and (B)
FHV titers in Wolbachia-free flies (black), wAu- (blue), wSh- (red)
and wAna-infected flies (light blue). Points represent the mean
value of 2 replicates. Error bars are standard errors. Significance
was tested using polynomial regressions with backward model
selection to remove non-significant terms. For DCV, the selected
model was: log2(meantiter) =m+strain+day+day2+day3+strain6
day+strain6day2. For FHV, the selected model was: log2(meanti-
ter) =m+strain+day+day2+strain6day+strain6day2. Comparisons
with the Wolbachia-free flies showed that only wAu-infected flies
significantly reduced viral titres, with the strain-by-day interaction
(DCV: P,0.0001; FHV: P,0.0001) and the quadratic strain-by-
day interaction being significant (DCV: P,0.0001; FHV: P,
0.0001), indicating a slower accumulation of DCV and FHV
compared to the controls.
(TIF)
Figure S3 Immune gene and Dnmt2 expression levels
after viral infection. (A–B) Expression of Drosomycin after (A)
DCV and (B) FHV infection. (C–D) Expression of Diptericin after
(C) DCV and (D) FHV infection. (E–F) Expression of Dnmt2 after
(E) DCV and (F) FHV infection. Expression levels relative to the
fly gene Actin 5c were normalised based on the qPCR plate effect
(see Material and Methods). Symbols above the bars give the
significance relative to the Wolbachia-free controls based on a
Dunnett’s test (*: P,0.05; **: P,0.01; ***: P,0.001).
(TIF)
Table S1 Cox’s proportional hazards mixed-effect
model on virus- and Ringer-infected flies. The strain-by-
treatment interaction can be interpreted as the protective effect
corrected for the between-strain variation in Ringer-infected flies.
(DOC)
Table S2 MLST genes used to build the Wolbachia
phylogeny.
(DOC)
Table S3 Primers and probes used in this study.
(DOC)
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